Adnane Remmal

Recent publications · Crossref

5 total works indexed

1. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

   · 2004 · cited 3,358x

2. Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines

   · 2010 · cited 1,575x

3. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

   · 2008 · cited 1,214x

4. Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

   · 2011 · cited 1,151x

5. The BioGRID interaction database: 2017 update

   · 2016 · cited 872x

via Crossref · CC0